Lyme disease

Pediatric Infectious Disease Journal

Volumn 18, Issue 10, 1999, Pages 913-925

  Sood, Sunil K ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

Borreliosis; Children; Lyme disease

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G;

ANTIBIOTIC THERAPY; BORRELIA BURGDORFERI; CHILD; CLINICAL FEATURE; GEOGRAPHIC DISTRIBUTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYME DISEASE; ORAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEROLOGY; TICK BITE;

ANIMALS; ANTI-BACTERIAL AGENTS; BABESIOSIS; CHILD; EHRLICHIOSIS; EUROPE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; LYME DISEASE; PROGNOSIS; SEROLOGIC TESTS; UNITED STATES;

EID: 0032829995     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199910000-00017     Document Type: Review

References (98)

1. CDC. Lyme disease: United States, 1995. MMWR 1996;45: 481-4.
2. Dennis DT. Epidemiology, ecology and prevention of Lyme disease. In: Rahn DT, Evans J, eds. Lyme disease. Philadelphia: American College of Physicians, 1998:7-34.
3. Lane RS, Quistad GB. Borreliacidal factor in the blood of the western fence lizard (Sceloporus occidentalis). J Parasitol 1998;84:29-34.
4. Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis 1986;154:295-300.
5. Steere AC. Lyme disease: a growing threat to urban populations. Proc Natl Acad Sci USA 1994;91:2378-83.
6. Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut: Pediatric Lyme Disease Study Group. N Engl J Med 1996;335: 1270-4.
7. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7-17.
8. Nadelman RB, Nowakowski J, Forseter G, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 1996;100:502-8.
9. Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 1985;35:47-53.
10. Kuiper H, de Jongh BM, van Dam AP, et al. Evaluation of central nervous system involvement in Lyme borreliosis patients with a solitary erythema migrans lesion. Eur J Clin Microbiol Infect Dis 1994;13:379-87.
11. Nadelman RB, Wormser GP. Erythema migrans and early Lyme disease. Am J Med 1995; 98:15S-23S.
12. Masters E, Granter S, Duray P, Cordes P. Physician-diagnosed erythema migrans and erythema migrans-like rashes following Lone Star tick bites. Arch Dermatol 1998; 134:955-60.
13. Kirkland KB, Klimko TB, Meriwether RA, et al. Erythema migrans-like rash illness at a camp in North Carolina: a new tick-borne disease? Arch Intern Med 1997;157:2635-41.
14. Barbour AG, Maupin GO, Teltow GJ, Carter CJ, Piesman J. Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness. J Infect Dis 1996;173:403-9.
15. Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann Intern Med 1977;86:685-98.
16. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987;107:725-31.
17. Smith V, Traquina DN. Pediatric bilateral facial paralysis. Laryngoscope 1998;108:519-23.
18. Christen HJ, Hanefeld F, Eiffert H, Thomssen R. Epidemiology and clinical manifestations of Lyme borreliosis in childhood: a prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl 1993;386:1-75.
19. Belman AL, Iyer M, Coyle PK, Dattwyler R. Neurologic manifestations in children with North American Lyme disease. Neurology 1993;43:2609-14.
20. Kan L, Sood SK, Maytal J. Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol 1998;18:439-41.
21. Eppes SC, Nelson DK, Lewis LL, Klein JD. Characterization of Lyme meningitis and comparison with viral meningitis in children. Pediatrics 1999;103:957-60.
22. Bingham PM, Galetta SL, Athreya B, Sladky J. Neurologic manifestations in children with Lyme disease. Pediatrics 1995;96:1053-6.
23. Feder HM Jr., Zalneraitis EL, Reik L Jr. Lyme disease: acute focal meningoencephalitis in a child. Pediatrics 1988;82: 931-4.
24. Luft BJ, Steinman CR, Neimark HC, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 1992;267:1364-7.
25. Belman AL, Reynolds L, Preston T, Postels D, Grimson R, Coyle PK. Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy. Arch Pediatr Adolesc Med 1997;151:1224-8.
26. Shapiro ED, Gerber MA. Lyme disease and facial nerve palsy [Editorial]. Arch Pediatr Adolesc Med 1997;151:1183-4.
27. Sood SK. Facial palsy in Lyme disease [Letter]. Arch Pediatr Adolesc Med 1998;152:928-9.
28. Niemann G, Koksal MA, Oberle A, Michaelis R. Facial palsy and Lyme borreliosis: long-term follow-up of children with antibiotically untreated "idiopathic" facial palsy. Klin Padiatr 1997;209:95-9.
29. Steere AC. Musculoskeletal features of Lyme disease. In: Rahn DT, Evans J, eds. Lyme disease. Philadelphia: American College of Physicians, 1998:107-22.
30. Klein J, Stanek G, Bittner R, Horvat R, Holzinger C, Glogar D. Lyme borreliosis as a cause of myocarditis and heart muscle disease. Eur Heart J 1991; 12(Suppl D):73-5.
31. Woolf PK, Lorsung EM, Edwards KS, et al. Electrocardiographic findings in children with Lyme disease. Pediatr Emerg Care 1991;7:334-6.
32. Gerber MA, Zemel LS, Shapiro ED. Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics 1998;102:905-8.
33. Szer IS, Taylor E, Steere AC. The long-term course of Lyme arthritis in children. N Engl J Med 1991;325:159-63.
34. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;323: 1438-44.
35. Shapiro ED. Lyme disease. Pediatr Rev 1998;19:147-54.
36. Bloom BJ, Wyckoff PM, Meissner HC, Steere AC. Neurocognitive abnormalities in children after classic manifestations of Lyme disease. Pediatr Infect Dis J 1998;17:189-96.
37. Belman AL, Coyle PK, Roque C, Cantos E. MRI findings in children infected by Borrelia burgdorferi. Pediatr Neurol 1992;8:428-31.
38. Oksi J, Kalimo H, Marttila RJ, et al. Inflammatory brain changes in Lyme borreliosis: a report on three patients and review of literature. Brain 1996;119:2143-54.
39. Adams WV, Rose CD, Eppes SC, Klein JD. Cognitive effects of Lyme disease in children. Pediatrics 1994;94:185-9.
40. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant: Lyme Disease Vaccine Study Group. N Engl J Med 1998;339:209-15.
41. Sood SK, Salzman MB, Johnson BJ, et al. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic. J Infect Dis 1997; 175:996-9.
42. Feder HM Jr., Gerber MA, Krause PJ, Ryan R, Shapiro ED. Early Lyme disease: a flu-like illness without erythema migrans. Pediatrics 1993;91:456-9.
43. Schlesinger PA, Duray PH, Burke BA, Steere AC, Stillman MT. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med 1985;103: 67-8.
44. MacDonald AB. Gestational Lyme borreliosis: implications for the fetus. Rheum Dis Clin North Am 1989;15:657-77.
45. Weber K, Bratzke H, Neubert U, Wilske B, Duray PH. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J 1988;7:286-9.
46. Markowitz LE, Steere AC, Benach JL, Slade JD, Broome CV. Lyme disease during pregnancy. JAMA 1986;255:3394-6.
47. Maraspin V, Cimperman J, Lotric Furlan S, Pleterski Rigler D, Strle F. Treatment of erythema migrans in pregnancy. Clin Infect Dis 1996;22:788-93.
48. Williams CL, Strobino B, Weinstein A, Spierling P, Medici F. Maternal Lyme disease and congenital malformations: a cord blood serosurvey in endemic and control areas. Paediatr Perinat Epidemiol 1995;9:320-30.
49. Nadal D, Hunziker UA, Bucher HU, Hitzig WH, Duc G. Infants born to mothers with antibodies against Borrelia burgdorferi at delivery. Eur J Pediatr 1989;148:426-7.
50. Strobino B, Abid S, Gewitz M. Maternal Lyme disease and congenital heart disease: a case-control study in an endemic area. Am J Obstet Gynecol 1999;180:711-16.
51. Nadelman RB, Horowitz HW, Hsieh TC, et al. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 1997;337:27-30.
52. Krause PJ, Telford SR, Spielman A, et al. Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness. JAMA 1996;275:1657-60.
53. Dressler F. Lyme borreliosis in European children and adolescents. Clin Exp Rheumatol 1994;12(Suppl 10):S49-54.
54. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990: a prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992;115: 399-423.
55. Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995;333:1319-27.
56. Pohl-Koppe A, Wilske B, Weiss M, Schmidt H. Borrelia lymphocytoma in childhood. Pediatr Infect Dis J 1998;17: 423-6.
57. Dammin GJ. Erythema migrans: a chronicle. Rev Infect Dis 1989;11:142-51.
58. Huppertz HI, Karch H, Suschke HJ, et al. Lyme arthritis in European children and adolescents: The Pediatric Rheumatology Collaborative Group. Arthritis Rheum 1995;38: 361-8.
59. Ley C, Le C, Olshen EM, Reingold AL. The use of serologic tests for Lyme disease in a prepaid health plan in California. JAMA 1994;271:460-3.
60. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993;269:1812-16.
61. Seltzer EG, Shapiro ED. Misdiagnosis of Lyme disease: when not to order serologic tests. Pediatr Infect Dis J 1996;15: 762-3.
62. Burlington DB. FDA Public Health advisory: assays for antibodies to Borrelia burgdorferi: limitations, use, and interpretation for supporting a clinical diagnosis of Lyme disease. Publication 1997-520-050 July 7, 1997. Washington, DC: US Government Printing Office, 1997.
63. Goodman JL, Bradley JF, Ross AE, et al. Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med 1995;99:6-12.
64. Bakken LL, Callister SM, Wand PJ, Schell RF. Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program. J Clin Microbiol 1997;35:537-43.
65. Hilton E, Devoti J, Sood S. Recommendation to include OspA and OspB in the new immunoblotting criteria for serodiagnosis of Lyme disease. J Clin Microbiol 1996;34:1353-4.
66. CDC. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR 1995;44:590-1.
67. Craven RB, Quan TJ, Bailey RE, et al. Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation. Emerg Infect Dis 1996;2:136-40.
68. Hilton E, Tramontano A, Devoti J, Sood SK. Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. J Clin Microbiol 1997; 35:774-6.
69. Sood SK, Zemel LS, Ilowite NT. Interpretation of immunoblot in pediatric Lyme arthritis. J Rheumatol 1995;22:758-61.
70. Jain VK, Hilton E, Maytal J, Dorante G, Ilowite NT, Sood SK. Immunoglobulin M immunoblot for diagnosis of Borrelia burgdorferi infection in patients with acute facial palsy. J Clin Microbiol 1996;34:2033-5.
71. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease: dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1988;319:1441-6.
72. Steere AC. Seronegative Lyme disease. JAMA 1993;270: 1369.
73. Schutzer SE, Coyle PK, Belman AL, Golightly MG, Drulle J. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 1990;335: 312-15.
74. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994;330:229-34.
75. Halperin JJ. Nervous system Lyme disease. J Neurol Sci 1998;153:182-91.
76. Callister SM, Schell RF, Case KL, Lovrich SD, Day SP. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J Infect Dis 1993;167:158-64.
77. Sigal LH. Use of the laboratory in the confirmation and management of Lyme disease. In: Rahn DT, Evans J, eds. Lyme disease. Philadelphia: American College of Physicians, 1998:167-88.
78. Karlsson M, Hammers Berggren S, Lindquist L, Stiernstedt G, Svenungsson B. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994;44:1203-7.
79. Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med 1983; 99:22-6.
80. Lochary ME, Lockhart PB, Williams WT Jr. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 1998;17: 429-30.
81. Dattwyler RJ, Grunwaldt E, Luft BJ. Clarithromycin in treatment of early Lyme disease: a pilot study. Antimicrob Agents Chemother 1996;40:468-9.
82. Luft BJ, Dattwyler RJ, Johnson RC, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double-blind, randomized, controlled trial. Ann Intern Med 1996;124:785-91.
83. Strle F, Maraspin V, Lotric Furlan S, Ruzic Sabljic E, Cimperman J. Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans. Infection 1996; 24:64-8.
84. Nadelman RB, Nowakowski J, Wormser GP. A Lyme disease controversy: duration of treatment [Letter]. Arch Intern Med 1997;157:697, 700.
85. Steere AC. Musculoskeletal manifestations of Lyme disease. Am J Med 1995;98:44S-48S.
86. Gross DM, Forsthuber T, Tary Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998;281:703-6.
87. Wang TJ, Sangha O, Phillips CB, et al. Outcomes of children treated for Lyme disease. J Rheumatol 1999;25:2249-53.
88. Shadick NA, Phillips CB, Logigian EL, et al. The long-term clinical outcomes of Lyme disease: a population-based retrospective cohort study. Ann Intern Med 1994;121:560-7.
89. Fish D. Environmental risk and prevention of Lyme disease. Am J Med 1995;98:2S-8S.
90. Shapiro ED, Gerber MA, Holabird NB, et al. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med 1992;327:1769-73.
91. Matuschka FR, Spielman A. Risk of infection from and treatment of tick bite. Lancet 1993;342:529-30.
92. Fikrig E, Telford SR 3d, Barthold SW, Kantor FS, Spielman A, Flavell RA. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci USA 1992;89:5418-21.
93. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease: recombinant outer-surface protein A: Lyme Disease Vaccine Study Consortium. N Engl J Med 1998;339:216-22.
94. Kalish RA, Leong JM, Steere AC. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 1993;61:2774-9.
95. Fraser CM, Casjens S, Huang WM, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997;390:580-6.
96. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995;33:419-27.
97. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 1996;34:1-9.
98. Johnson BJ, Robbins KE, Bailey RE, et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis 1996; 174:346-53.